Skip to main content

Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements

Access & Citations

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

Trials

ISSN: 1745-6215